Autologous hematopoietic stem cell transplant with melphalan and thiotepa is safe and feasible in pediatric patients with low normalized glomerular filtration rate

Amanda M. Termuhlen, Alfred Grovas, Kathryn Klopfenstein, Robin Rosselet, Thomas G. Gross

Research output: Contribution to journal › Article › peer-review

6 Scopus citations

Fingerprint

Dive into the research topics of 'Autologous hematopoietic stem cell transplant with melphalan and thiotepa is safe and feasible in pediatric patients with low normalized glomerular filtration rate'. Together they form a unique fingerprint.

Medicine & Life Sciences